众生药业股价下跌1.60% 公司推进MASH治疗药物研发

Group 1 - The stock price of Zhongsheng Pharmaceutical closed at 19.73 yuan on August 7, 2025, down 1.60% from the previous trading day [1] - The trading volume on that day was 869 million yuan, with a turnover rate of 5.74%, and the total market capitalization reached 16.769 billion yuan [1] - Zhongsheng Pharmaceutical operates in the traditional Chinese medicine industry, focusing on drug research, production, and sales, with products spanning traditional Chinese medicine, chemical drugs, and biological drugs [1] Group 2 - The company announced on its interactive platform that it will advance the RAY1225 project for the treatment of metabolic-associated fatty liver disease, with progress dependent on research and development strategies [1] - On August 7, the net outflow of main funds was 75.0972 million yuan, with a cumulative net outflow of 37.0842 million yuan over the past five days [1]